Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours (Q36615874)
Jump to navigation
Jump to search
scientific article published on May 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours |
scientific article published on May 2005 |
Statements
1 reference
Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours (English)
1 reference
Awada A
1 reference
Hendlisz A
1 reference
Gil T
1 reference
Bartholomeus S
1 reference
Mano M
1 reference
de Valeriola D
1 reference
Strumberg D
1 reference
Brendel E
1 reference
Haase CG
1 reference
Schwartz B
1 reference
Piccart M
1 reference
1 May 2005
1 reference
1 reference
1855-1861
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference